newsfilter
← Latest News
GlobeNewswire·

Eyenovia Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Advanced Phase 3 CHAPERONE study of MicroPine as a treatment of pediatric progressive myopia with preparations for interim analysis this quarter Commenced the manufacture of registration batches of Mydcombi in its